Core Insights - Zhendermedical's stock increased by 6.25% to 68.90 CNY per share, with a trading volume of 297 million CNY and a turnover rate of 1.68%, resulting in a total market capitalization of 18.358 billion CNY [1] Company Overview - Zhendermedical, established on August 18, 1994, and listed on April 12, 2018, is located in Shaoxing City, Zhejiang Province. The company specializes in the production, research, and sales of medical dressings [1] - The main revenue composition includes: - Surgical infection control: 43.04% - Basic care: 20.46% - Stoma and modern wound care: 18.59% - Pressure treatment and fixation: 10.75% - Infection control protection: 6.58% - Others: 0.58% [1] Shareholder Insights - Zhendermedical's top circulating shareholder is a fund under China Merchants Fund, specifically the China Merchants Core Competitiveness Mixed A (014412), which increased its holdings by 581,000 shares to a total of 3.4286 million shares, representing 1.29% of circulating shares. The estimated floating profit today is approximately 13.886 million CNY [2] - The fund was established on April 13, 2022, with a latest scale of 2.993 billion CNY. Year-to-date returns are 20.14%, ranking 4429 out of 8161 in its category, while the one-year return is 23.01%, ranking 4129 out of 8021. Since inception, the return is 56.25% [2] Fund Manager Profile - The fund manager for China Merchants Core Competitiveness Mixed A (014412) is Zhu Hongyu, who has a cumulative tenure of 14 years and 154 days. The total asset scale of the fund is 4.964 billion CNY, with the best fund return during his tenure being 54.07% and the worst being -12.86% [3] Fund Holdings - Another fund under China Merchants Fund, the China Merchants Social Responsibility Mixed A (018309), holds 1.367 million shares of Zhendermedical, accounting for 2.96% of the fund's net value, ranking as the tenth largest holding. The estimated floating profit today is approximately 5.5364 million CNY [4] - This fund was established on April 26, 2023, with a latest scale of 974 million CNY. Year-to-date returns are 27.67%, ranking 3282 out of 8161, while the one-year return is 29.91%, ranking 3182 out of 8021. Since inception, the return is 8.49% [4]
振德医疗股价涨6.25%,招商基金旗下1只基金位居十大流通股东,持有342.86万股浮盈赚取1388.6万元